In response to the safety alert issued by the FDA on Dec. 3, 2009 regarding the STERIS Corp. System 1®, Advanced Sterilization Products (ASP) has developed comprehensive solutions, new resources, financial assistance and educational initiatives to help those complying with the FDA safety alert to better navigate through the transition, including an informational Webinar series that launches on Friday, Feb. 12, 2010.
The Webinar series will provide important information for healthcare professionals concerned about the steps to ensure a smooth transition. The first ASP-sponsored Webinar, "Transitioning from the STERIS System 1?" aims to help facilities maintain standards of patient care and infection prevention by answering pressing questions such as:
-- What are ASP's alternatives to the SS1?
-- How do I minimize impact on staff and avoid interruptions to procedures?
-- How do I start making the transition and what do I need to know now?
-- What will the sterilization process be after the transition and will it result in a higher standard of care?
-- What financial and educational assistance is ASP offering to help facilities with the transition?
Participants will hear from a panel of ASP representatives who have been working firsthand with facilities as they transition from the SS1. Participant questions will be answered at the conclusion of the Webinar. The Webinar is free of charge and will be held on Feb. 12, 2010 from 12 p.m. to 1 p.m. ET. Registration can be accessed at
http://www.visualwebcaster.com/event.asp?id=65597
.
The Sterile Processing Conference Survival Guide: How to Make the Most of Your Next Event
March 25th 2025From expert speakers to cutting-edge tools, sterile processing conferences, like the 2025 HSPA Annual Conference and the SoCal SPA's Spring Conference, offer unmatched opportunities to grow your skills, expand your network, and strengthen your department's infection prevention game.
Redefining Material Compatibility in Sterilization: Insights From AAMI TIR17:2024
March 24th 2025AAMI TIR17:2024 provides updated, evidence-based guidance on material compatibility with sterilization modalities. It offers essential insights for medical device design and ensures safety without compromising functionality.